From a distance the two look identical, which is where the honest comparison has to begin. Both promise a GLP-1 prescription through a phone, both deliver a vial or a pen and one of them charges a third of the price. We understand why the comparison comes up, because we make the more expensive promise. This page is about what the extra money is for.
- The $99 app is built to sell medication. Our membership is built to explain your biology first.
- The app's real cost appears later, in dose-escalation repricing and program fees that climb as your prescription climbs.
- Compounded copies are the other difference. We prescribe branded, FDA-approved medication only.
- Our $299 fee never changes with your dose and we take nothing from the pharmacy bill.
At a glance
| The $99 semaglutide app | GoodLife Health | |
|---|---|---|
| What is actually for sale | A recurring prescription | A clinical relationship |
| Labs before prescribing | Rarely and often optional add-ons | A comprehensive Biomarker Audit every 90 days, included |
| Medication source | Commonly compounded copies at introductory prices | Branded, FDA-approved only: Wegovy, Zepbound, Ozempic, Mounjaro |
| What happens when your dose rises | The monthly price usually rises with it | The fee is flat at $299, whatever the dose |
| Who profits when your dose climbs | The platform | Nobody we are paid by |
The price you see and the price you pay
The $99 figure is real and it is genuinely low. It is also the first rung of a staircase. Weight-loss platforms commonly structure their pricing so the introductory dose carries the advertised fee and the monthly bill climbs as the prescriber titrates you upward. By the time a patient is on a meaningful dose, the $99 has commonly become several hundred dollars a month and the programs that quoted it are charging for the dose rather than for the care. This is not a secret. The pricing pages show it once you know to look for the dose columns.
The second difference is the medication itself. Compounded semaglutide and tirzepatide are copies made when the branded drug was in shortage and the FDA's position is that compounded drugs do not undergo the agency's premarket review for safety, quality or effectiveness and should be used only when an approved drug cannot meet the patient's needs. The agency has received reports of dosing errors and adverse events tied to compounded copies. We do not prescribe them at any price. If the $99 quote is for a compounded vial, the cheap option is a different drug and the comparison was over before it started.
What the $299 is for
Our membership fee pays for the part the app skips. Before anyone prescribes anything, a clinician licensed in your state reviews your history and a comprehensive Biomarker Audit measures what guesswork never touches. ApoB, Lp(a), hs-CRP, HbA1c, lipids, insulin markers and full hormone and thyroid panels. The audit repeats every 90 days. When a plateau comes, as it does for most patients eventually, someone is watching your fasting insulin and your thyroid rather than answering with a dose increase.
That sequence matters because weight that will not move is sometimes a thyroid question, sometimes an insulin question, sometimes a hormone question and sometimes the drug itself. The STEP 1 trial showed an average body-weight reduction of about 15 percent over 68 weeks on semaglutide 2.4 mg with lifestyle support and individual results varied. Trial averages are not promises. They are arguments for measuring the person in front of you.
The fee is $299 a month, month to month after a two-month start and it never changes with your prescription. Medication is prescribed to your pharmacy and billed by the pharmacy at its own price. We set nothing on that transaction, see nothing and take nothing from it. When the branded drug is the right clinical answer and the pharmacy's price for it is lower than the app's compounded bundle, the honest comparison sometimes lands on our side of the table at the pharmacy line too.
The year-one math, honestly
Manufacturers' own self-pay prices, as published in September 2026. Through NovoCare, Wegovy pens run $199 a month for the first two fills on a new-patient offer through December 2026, then $349 a month. The Wegovy pill starts from $149 a month at lower doses. Through LillyDirect, Zepbound vials run $299 to $449 a month depending on dose. Those are pharmacy-side figures and they apply to us as to anyone.
So a fair year-one comparison shows the app's program fee plus its escalated dose price, against our $3,588 plus the pharmacy's own price for a branded drug. Depending on the dose you titrate to, those totals can cross. We are comfortable with that comparison because the thing that does not cross is the structure. One side's revenue grows when your dose grows and ours cannot.
What the app's follow-up looks like in month four
The difference between the two models is easiest to see when something goes wrong. On the app, a plateau at month four usually produces one of two answers. Either the dose goes up, which raises your bill or you are told to be more patient, which raises nobody's bill and answers nothing. Neither answer involved a measurement.
In the membership, a plateau at month four produces a panel. Your fasting insulin, your thyroid panel, your HbA1c and your hormone picture are re-drawn and read by the same clinician who ordered them. If the stall is insulin resistance, the protocol addresses insulin resistance. If it is a thyroid value drifting at the edge of normal, that gets addressed. If the drug is doing its work and the trend simply needs time, we tell you that and the dose stays where it is.
The difference is not intelligence or effort. It is incentive. The app makes money when the dose goes up and makes nothing when it goes down, so the advice arrives pre-shaped by that fact. Our fee is the same at any dose, so the advice has no stake in the answer. That is the entire reason the flat fee exists and it is also why we can publish the comparison above without hedging it.
Who should pick the app
Some readers should. If you have had full labs recently, you know your metabolic picture and your only goal is the lowest possible price on a compounded vial, the app is the rational choice and we are not it. If you want a prescription this afternoon with no history and no follow-up, we will feel slow. If you are budget-capped at $99 a month all-in, the flat-fee model is not for you yet and we would rather say that than sell you a membership you will resent in month three.
If instead you want to know why the weight will not move, a dose that never gets financially weaponized against you and a clinician who is still reading your labs in month nine, the eligibility check is the first step. Not everyone is accepted and you are never charged unless a clinician accepts you into care.
The app is priced to sell the drug. The membership is priced to explain your biology. Those are different products and only one of them keeps working when the plateau arrives.
Frequently Asked Questions
Is GoodLife Health more expensive than a $99 app?
The membership is $299 a month after a two-month start and medication is billed separately by your pharmacy at pharmacy cost. Whether the year-one total is higher than an app's depends on the dose you titrate to, because app pricing commonly climbs with the dose. Our fee never does.
Do you offer compounded semaglutide at a lower price?
No. We prescribe branded, FDA-approved medication only. The FDA has stated that compounded drugs do not undergo its premarket review for safety, quality or effectiveness and we do not offer them at any price.
Will my fee go up when my dose goes up?
No. The fee is $299 a month whatever is prescribed and whatever the dose. There is no molecule upcharge and no dose upcharge, because we take nothing from the pharmacy transaction.
Does the membership include the medication cost?
No. The fee covers the clinician relationship and the quarterly Biomarker Audit. Medication is a separate charge billed by the pharmacy you choose, at that pharmacy's own price.
What labs does the membership include?
A comprehensive Biomarker Audit every 90 days covering ApoB, Lp(a), hs-CRP, HbA1c, lipids, insulin markers and full hormone and thyroid panels, drawn through the Beluga Health lab network.
Can I join if I am already on a GLP-1 from an app?
Often, yes. Many members arrive on a prescription from elsewhere, with a dose that kept climbing and no one watching why. Your clinician reviews your history and labs before any change and dose minimization with outcome maximization is the standing protocol.
What if I want to leave after a few months?
After the first two months you can cancel anytime with no penalty. The quarterly panels you have already received stay yours.
The question to ask any platform, including us
The comparison in this article is checkable rather than rhetorical and the way to check it is a short list of questions you can put to any weight-loss platform, including this one.
First: what labs did you order before prescribing and when do you re-draw them? If the answer is a symptom quiz and no panel, the prescribing is guesswork. If the panel exists but never repeats, the guesswork only happens once.
Second: what does month nine cost at the dose I am likely to reach? Read the pricing page's dose columns rather than its banner. If the advertised figure only applies to the introductory dose, the real number lives three columns to the right.
Third: is the medication compounded? A yes tells you the price is built on copies the FDA has raised concerns about and the comparison with a branded price was over before it started.
Fourth: what happens to your revenue if my dose comes down? With us the answer is nothing and the fee is the same at any dose. If a platform cannot answer that cleanly, the answer is the reason for the price.
We would rather be compared honestly than chosen quickly. The eligibility check takes a few minutes, a clinician reviews every application and you are never charged unless a clinician accepts you into care.
One last thing
Ask any platform you are comparing one question. What does month nine cost at the dose I am likely to reach? Then ask who is measuring your fasting insulin while you take it. The first question prices the drug. The second prices the medicine.
Related Guides
- The GLP-1 pricing guide: Wegovy, Zepbound, Ozempic
- Cardiometabolic Optimization: the definitive guide
- Why we never prescribe compounded GLP-1
- Who the membership is and is not for
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/